|
|||||
|
|
Liraglutide reduces cardiac adipose tissue in type 2 diabetes: A secondary analysis of the LIRAFLAME randomized placebo-controlled trial |
|
| Authors: | Ida K. B. Rasmussen MD Emilie H. Zobel MD Rasmus S. Ripa MD PhD Bernt J. von Scholten MD PhD Viktor R. Curovic MD Jacob K. Jensen MD Andreas Kjaer MD PhD Tine W. Hansen MD PhD Peter Rossing MD PhD |
| Affiliation: | 1. Steno Diabetes Centre Copenhagen, Gentofte, Denmark;2. Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet, Kobenhavn, Denmark University of Copenhagen, Copenhagen, Denmark;3. Steno Diabetes Centre Copenhagen, Gentofte, Denmark Novo Nordisk A/S, Søborg, Denmark;4. Steno Diabetes Centre Copenhagen, Gentofte, Denmark University of Copenhagen, Copenhagen, Denmark |
| Abstract: | |
| Keywords: | cardiovascular disease diabetes complications GLP-1 liraglutide randomized trial type 2 diabetes |